• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic relevance of molecular measurable residual disease detection in AML with mutated .

作者信息

Vonk Christian M, Boertjes Emma L, Kavelaars Francois G, Rijken Melissa, Konijnenburg Jolinda M L, Cromwell Roxanne E, Löwenberg Bob, Grob Tim, Valk Peter J M

机构信息

Department of Hematology, Erasmus MC Cancer Institute University Medical Center Rotterdam Rotterdam the Netherlands.

出版信息

Hemasphere. 2024 Aug 15;8(8):e141. doi: 10.1002/hem3.141. eCollection 2024 Aug.

DOI:10.1002/hem3.141
PMID:39148661
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11326717/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/11326717/c07c30bb6d6c/HEM3-8-e141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/11326717/c07c30bb6d6c/HEM3-8-e141-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae04/11326717/c07c30bb6d6c/HEM3-8-e141-g001.jpg

相似文献

1
Prognostic relevance of molecular measurable residual disease detection in AML with mutated .伴有突变的急性髓系白血病中分子可测量残留病检测的预后相关性
Hemasphere. 2024 Aug 15;8(8):e141. doi: 10.1002/hem3.141. eCollection 2024 Aug.
2
The effect of the detection of minimal residual disease for the prognosis and the choice of post-remission therapy of intermediate-risk acute myeloid leukemia without FLT3-ITD, NPM1 and biallelic CEBPA mutations.无 FLT3-ITD、NPM1 和双等位 CEBPA 突变的中危急性髓系白血病微小残留病检测对预后和缓解后治疗选择的影响。
Hematology. 2021 Dec;26(1):179-185. doi: 10.1080/16078454.2021.1880753.
3
Clinical significance of FLT3-ITD/CEBPA mutations and minimal residual disease in cytogenetically normal acute myeloid leukemia after hematopoietic stem cell transplantation.FLT3-ITD/CEBPA 基因突变和细胞遗传学正常的急性髓细胞白血病造血干细胞移植后微小残留病的临床意义。
J Cancer Res Clin Oncol. 2021 Sep;147(9):2659-2670. doi: 10.1007/s00432-021-03530-9. Epub 2021 Feb 7.
4
Characterization of CEBPA Mutations and Polymorphisms and their Prognostic Relevance in De Novo Acute Myeloid Leukemia Patients.CEBPA突变和多态性的特征及其在初发急性髓系白血病患者中的预后相关性
Asian Pac J Cancer Prev. 2015;16(9):3785-92. doi: 10.7314/apjcp.2015.16.9.3785.
5
NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value.阿根廷儿童急性髓系白血病患者中的NPM1、FLT3和CEBPA突变：发生率及预后价值
Int J Hematol. 2016 Nov;104(5):582-590. doi: 10.1007/s12185-016-2064-5. Epub 2016 Jul 19.
6
[Restratifying the prognosis of acute myeloid leukemia patients with CEBPA double mutations based on CSF3R mutations and measurable residual disease].基于CSF3R突变和可测量残留病重新评估伴有CEBPA双突变的急性髓系白血病患者的预后
Zhonghua Xue Ye Xue Za Zhi. 2022 Dec 14;43(12):1021-1027. doi: 10.3760/cma.j.issn.0253-2727.2022.12.008.
7
Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.具有高危分子特征的细胞遗传学正常的急性髓系白血病中CEBPA突变的预后意义以及与之相关的基因和微小RNA表达特征：癌症与白血病B组研究
J Clin Oncol. 2008 Nov 1;26(31):5078-87. doi: 10.1200/JCO.2008.17.5554. Epub 2008 Sep 22.
8
Prognostic relevance of and mutations in cytogenetically normal adult AML patients.细胞遗传学正常的成年急性髓系白血病患者中[具体基因]和[具体基因]突变的预后相关性
Am J Blood Res. 2023 Feb 15;13(1):28-43. eCollection 2023.
9
Sporadic and Familial Acute Myeloid Leukemia with CEBPA Mutations.散发性和家族性伴有 CEBPA 突变的急性髓系白血病。
Curr Hematol Malig Rep. 2023 Oct;18(5):121-129. doi: 10.1007/s11899-023-00699-3. Epub 2023 Jun 1.
10
Detection of measurable residual disease may better predict outcomes than mutations based on next-generation sequencing in acute myeloid leukaemia with biallelic mutations of CEBPA.在存在双等位基因突变 CEBPA 的急性髓细胞白血病中，基于下一代测序的可测量残留疾病检测可能比突变检测更好地预测预后。
Br J Haematol. 2020 Aug;190(4):533-544. doi: 10.1111/bjh.16535. Epub 2020 Feb 23.

本文引用的文献

1
Prognostic impact of CEBPA mutational subgroups in adult AML.CEBPA 突变亚组对成人 AML 的预后影响。
Leukemia. 2024 Feb;38(2):281-290. doi: 10.1038/s41375-024-02140-x. Epub 2024 Jan 16.
2
Prognostic Value of -Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.急性髓系白血病中-串联重复残留病的预后价值。
J Clin Oncol. 2023 Feb 1;41(4):756-765. doi: 10.1200/JCO.22.00715. Epub 2022 Oct 31.
3
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
成人 AML 的诊断与治疗：ELN 专家组代表发布的 2022 年国际专家建议
Blood. 2022 Sep 22;140(12):1345-1377. doi: 10.1182/blood.2022016867.
4
Molecular Minimal Residual Disease Detection in Acute Myeloid Leukemia.急性髓系白血病的分子微小残留病检测
Cancers (Basel). 2021 Oct 29;13(21):5431. doi: 10.3390/cancers13215431.
5
CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome.CEBPA 基因突变在 4708 例急性髓系白血病患者中的作用：bZIP 和 TAD 突变对预后的不同影响。
Blood. 2022 Jan 6;139(1):87-103. doi: 10.1182/blood.2020009680.
6
PPM1D mutations appear in complete remission after exposure to chemotherapy without predicting emerging AML relapse.PPM1D突变在接受化疗后完全缓解时出现，且无法预测急性髓系白血病（AML）复发的出现。
Leukemia. 2021 Sep;35(9):2693-2697. doi: 10.1038/s41375-021-01155-y. Epub 2021 Feb 15.
7
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia: A Systematic Review and Meta-analysis.有可测量残留病与急性髓系白血病患者生存结局的关联：系统评价和荟萃分析。
JAMA Oncol. 2020 Dec 1;6(12):1890-1899. doi: 10.1001/jamaoncol.2020.4600.
8
CCAAT enhancer binding protein alpha (CEBPA) biallelic acute myeloid leukaemia: cooperating lesions, molecular mechanisms and clinical relevance.CCAAT 增强子结合蛋白α（CEBPA）双等位基因突变急性髓系白血病：协同病变、分子机制及临床相关性。
Br J Haematol. 2020 Aug;190(4):495-507. doi: 10.1111/bjh.16534. Epub 2020 Feb 21.
9
Molecular Minimal Residual Disease in Acute Myeloid Leukemia.急性髓系白血病的分子微小残留病。
N Engl J Med. 2018 Mar 29;378(13):1189-1199. doi: 10.1056/NEJMoa1716863.
10
C/EBPα deregulation as a paradigm for leukemogenesis.C/EBPα失调作为白血病发生的一种范例。
Leukemia. 2017 Nov;31(11):2279-2285. doi: 10.1038/leu.2017.229. Epub 2017 Jul 19.